Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.
Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.
复制标题
DOI:
10.1016/j.biopsych.2017.09.028
复制
发表时间:
2018-03-15
影响因子:
10.6
通讯作者:
Shungu DC
中科院分区:
文献类型:
--
作者:
de la Fuente-Sandoval C;Reyes-Madrigal F;Mao X;León-Ortiz P;Rodríguez-Mayoral O;Jung-Cook H;Solís-Vivanco R;Graff-Guerrero A;Shungu DC
Abnormally elevated levels of γ-aminobutyric acid (GABA) in the medial prefrontal cortex (MPFC) have been reported in antipsychotic-free patients with schizophrenia. Whether such GABA elevations are also present in other brain regions and persist after antipsychotic treatment has not been previously investigated. Twenty-eight antipsychotic-naive first-episode psychosis (FEP) patients and 18 healthy control subjects completed the study. Following baseline proton magnetic resonance spectroscopy scans targeting the MPFC and a second region, the dorsal caudate, FEP patients were treated with oral risperidone for 4 weeks, at an initial dose of 1mg/day that was titrated as necessary based on clinical judgment. After the 4-week treatment period, both groups were brought back to undergo outcome MRS scans, which were identical to the scans conducted at baseline. At baseline, higher GABA levels were found both in the MPFC and in the dorsal caudate of FEP patients than in healthy control subjects. Following 4 weeks of antipsychotic treatment, GABA levels in FEP patients decreased relative to baseline in the MPFC, while decreasing only at the trend-level relative to baseline in the dorsal caudate. For either brain region, GABA levels at 4 weeks or post-treatment did not differ between FEP patients and healthy control subjects. The results of the present study have documented elevations of GABA levels in both the MPFC and, for the first time, in the dorsal caudate of antipsychotic-naive FEP patients, which normalized in both regions following 4 weeks of antipsychotic treatment.
登录
查看更多内容
DOI:
10.1016/j.nicl.2014.10.005
发表时间:
2014
期刊:
NeuroImage. Clinical
影响因子:
--
作者:
Marsman A;Mandl RC;Klomp DW;Bohlken MM;Boer VO;Andreychenko A;Cahn W;Kahn RS;Luijten PR;Hulshoff Pol HE
通讯作者:
Hulshoff Pol HE
影响因子:
6.6
作者:
Rowland, Laura M.;Kontson, Kimberly;Barker, Peter B.
通讯作者:
Barker, Peter B.
影响因子:
25.8
作者:
Kraguljac NV;White DM;Reid MA;Lahti AC
通讯作者:
Lahti AC
影响因子:
25.8
作者:
Merritt, Kate;Egerton, Alice;McGuire, Philip K.
通讯作者:
McGuire, Philip K.
影响因子:
11
作者:
Rowland LM;Krause BW;Wijtenburg SA;McMahon RP;Chiappelli J;Nugent KL;Nisonger SJ;Korenic SA;Kochunov P;Hong LE
通讯作者:
Hong LE